ZA200002604B - N-oxides of heterocyclic compounds with TNF and PDE-IV inhibiting activity. - Google Patents
N-oxides of heterocyclic compounds with TNF and PDE-IV inhibiting activity.Info
- Publication number
- ZA200002604B ZA200002604B ZA200002604A ZA200002604A ZA200002604B ZA 200002604 B ZA200002604 B ZA 200002604B ZA 200002604 A ZA200002604 A ZA 200002604A ZA 200002604 A ZA200002604 A ZA 200002604A ZA 200002604 B ZA200002604 B ZA 200002604B
- Authority
- ZA
- South Africa
- Prior art keywords
- pde
- tnf
- oxides
- heterocyclic compounds
- inhibiting activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9824160.7A GB9824160D0 (en) | 1998-11-04 | 1998-11-04 | Heterocyclic compounds and their therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200002604B true ZA200002604B (en) | 2001-05-28 |
Family
ID=10841838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200002604A ZA200002604B (en) | 1998-11-04 | 2000-05-25 | N-oxides of heterocyclic compounds with TNF and PDE-IV inhibiting activity. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1045845A1 (en) |
| JP (1) | JP2002528541A (en) |
| KR (1) | KR20010033842A (en) |
| CN (1) | CN1287555A (en) |
| AR (1) | AR021094A1 (en) |
| AU (1) | AU735574B2 (en) |
| BR (1) | BR9906719A (en) |
| CA (1) | CA2312430A1 (en) |
| CO (1) | CO5160316A1 (en) |
| GB (1) | GB9824160D0 (en) |
| HU (1) | HUP0100570A3 (en) |
| IL (1) | IL136398A0 (en) |
| NO (1) | NO20003439L (en) |
| NZ (1) | NZ504933A (en) |
| PE (1) | PE20001232A1 (en) |
| PL (1) | PL341732A1 (en) |
| RU (1) | RU2205830C2 (en) |
| SK (1) | SK10082000A3 (en) |
| TR (1) | TR200001941T1 (en) |
| TW (1) | TW546296B (en) |
| WO (1) | WO2000026208A1 (en) |
| ZA (1) | ZA200002604B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| DE10318610A1 (en) * | 2003-04-24 | 2004-11-11 | Elbion Ag | 7-azaindoles and their use as therapeutic agents |
| CN1878765A (en) * | 2003-09-15 | 2006-12-13 | 先灵公司 | Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors |
| US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000065219A (en) * | 1996-05-20 | 2000-11-06 | 마르크 젠너 | Quinoline Carboxamides as Thienef inhibitors and Pidi-4 Inhibitors |
| AU3102697A (en) * | 1996-06-19 | 1998-01-07 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
-
1998
- 1998-11-04 GB GBGB9824160.7A patent/GB9824160D0/en not_active Ceased
-
1999
- 1999-10-20 TW TW088118098A patent/TW546296B/en not_active IP Right Cessation
- 1999-11-02 CN CN99801954A patent/CN1287555A/en active Pending
- 1999-11-02 TR TR2000/01941T patent/TR200001941T1/en unknown
- 1999-11-02 EP EP99954132A patent/EP1045845A1/en not_active Withdrawn
- 1999-11-02 BR BR9906719-6A patent/BR9906719A/en not_active IP Right Cessation
- 1999-11-02 JP JP2000579596A patent/JP2002528541A/en active Pending
- 1999-11-02 AU AU10571/00A patent/AU735574B2/en not_active Ceased
- 1999-11-02 KR KR1020007007402A patent/KR20010033842A/en not_active Application Discontinuation
- 1999-11-02 CA CA002312430A patent/CA2312430A1/en not_active Abandoned
- 1999-11-02 HU HU0100570A patent/HUP0100570A3/en unknown
- 1999-11-02 IL IL13639899A patent/IL136398A0/en unknown
- 1999-11-02 SK SK1008-2000A patent/SK10082000A3/en unknown
- 1999-11-02 WO PCT/GB1999/003628 patent/WO2000026208A1/en not_active Application Discontinuation
- 1999-11-02 RU RU2000120469/04A patent/RU2205830C2/en not_active IP Right Cessation
- 1999-11-02 PL PL99341732A patent/PL341732A1/en not_active Application Discontinuation
- 1999-11-02 NZ NZ504933A patent/NZ504933A/en unknown
- 1999-11-03 PE PE1999001102A patent/PE20001232A1/en not_active Application Discontinuation
- 1999-11-04 AR ARP990105594A patent/AR021094A1/en not_active Application Discontinuation
- 1999-11-04 CO CO99069730A patent/CO5160316A1/en unknown
-
2000
- 2000-05-25 ZA ZA200002604A patent/ZA200002604B/en unknown
- 2000-07-03 NO NO20003439A patent/NO20003439L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1045845A1 (en) | 2000-10-25 |
| WO2000026208A1 (en) | 2000-05-11 |
| CA2312430A1 (en) | 2000-05-11 |
| HUP0100570A2 (en) | 2001-10-28 |
| NO20003439D0 (en) | 2000-07-03 |
| GB9824160D0 (en) | 1998-12-30 |
| IL136398A0 (en) | 2001-06-14 |
| KR20010033842A (en) | 2001-04-25 |
| RU2205830C2 (en) | 2003-06-10 |
| NO20003439L (en) | 2000-07-03 |
| AU1057100A (en) | 2000-05-22 |
| TW546296B (en) | 2003-08-11 |
| BR9906719A (en) | 2000-10-17 |
| CN1287555A (en) | 2001-03-14 |
| PE20001232A1 (en) | 2000-11-28 |
| NZ504933A (en) | 2001-10-26 |
| PL341732A1 (en) | 2001-05-07 |
| JP2002528541A (en) | 2002-09-03 |
| TR200001941T1 (en) | 2001-01-22 |
| AR021094A1 (en) | 2002-06-12 |
| AU735574B2 (en) | 2001-07-12 |
| SK10082000A3 (en) | 2001-01-18 |
| HUP0100570A3 (en) | 2002-12-28 |
| CO5160316A1 (en) | 2002-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9702034D0 (en) | Heterocyclic compounds of leukocita-adhesion-inhibitor and vla-4-antagonist activity | |
| GB2364059B (en) | Beta-Secretase enzyme compositions and methods | |
| IL130851A0 (en) | Heterocyclic compounds and their use for inhibiting beta-amyloid peptide | |
| PL332205A1 (en) | Heterocyclic thioesters and ketones | |
| EP0993299A4 (en) | N-oxides of heterocyclic esters, amides, thioesters, and ketones | |
| HK1027624A1 (en) | Solid-state fluorometer and methods of use therefor. | |
| HUP0103438A3 (en) | Needleless injector cartridge | |
| EP0996433A4 (en) | Methods for treatment of conditions associated with lactosylceramide | |
| EG21712A (en) | Treatment of insulin resistance | |
| GB9905275D0 (en) | Treatment of conditions associated with membrane-bound receptors and their function | |
| EP1071339A4 (en) | Treatment of animals with dihydroxyquinoline compounds | |
| IL147885A0 (en) | Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity | |
| ZA200002604B (en) | N-oxides of heterocyclic compounds with TNF and PDE-IV inhibiting activity. | |
| HK1020944A1 (en) | Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds | |
| ZA991233B (en) | Use of thiadiazolo pyridine derivatives. | |
| ZA981374B (en) | Pyridazin-3-one derivatives and their use | |
| ZA200006632B (en) | Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity. | |
| PL339493A1 (en) | Bis-ethers of 1-oxa, aza and thinaphtalen-2-ones as phospholamane inhibitors | |
| EP1172439A4 (en) | Thermostable enzyme having aminotransferase activity and gene encoding the same | |
| ZA981322B (en) | Pyridazin-3-one derivatives and their use | |
| ZA9710911B (en) | Substituted pyrimidinone and pyridone compounds and methods of use. | |
| ZA968981B (en) | Inhibitors of rotamase enzyme activity. | |
| IL138024A0 (en) | Inhibition of tnf activity | |
| AU9646998A (en) | Heterocyclic compounds and use thereof | |
| ZA972790B (en) | Heterocyclic compounds and their preparation and use. |